BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 27.28%184.26M | -4.79%1.07B | -15.19%563.3M | -18.18%336.81M | -39.82%144.77M | -12.68%1.13B | -13.70%664.17M | -12.27%411.66M | 19.89%240.55M | -28.19%1.29B |
Refunds of taxes and levies | ---- | -92.44%22.05K | -91.60%21.01K | -91.60%21.01K | ---- | -89.52%291.64K | -49.64%250.28K | -45.30%250.28K | --215.18K | 1,774.86%2.78M |
Cash received relating to other operating activities | 18.38%14.51M | -39.91%52.72M | -29.72%37.14M | -37.92%22.71M | -56.11%12.26M | 27.57%87.74M | -1.65%52.84M | 1.21%36.59M | 75.78%27.93M | -49.16%68.78M |
Cash inflows from operating activities | 26.58%198.77M | -7.35%1.12B | -16.28%600.46M | -19.83%359.54M | -41.56%157.03M | -10.80%1.21B | -12.93%717.26M | -11.33%448.5M | 24.09%268.7M | -29.52%1.36B |
Goods services cash paid | 15.26%232.45M | 23.11%1.02B | -9.34%546.32M | -11.92%372.82M | -19.36%201.68M | -9.09%830.95M | -24.64%602.61M | -29.63%423.29M | 2.76%250.1M | -44.05%914.04M |
Staff behalf paid | -6.21%53.31M | -1.89%180.34M | 1.75%139.71M | 4.34%99.32M | 4.10%56.84M | -9.28%183.8M | -15.02%137.32M | -20.67%95.18M | -21.66%54.6M | -12.32%202.6M |
All taxes paid | -16.45%1.94M | -97.17%925.35K | -89.35%3.29M | -87.70%3.29M | -88.42%2.32M | 18.86%32.67M | 180.51%30.84M | 200.57%26.74M | 129.83%20.06M | -12.95%27.49M |
Cash paid relating to other operating activities | 8.56%34.59M | -15.97%120.21M | 13.14%80.74M | -0.45%47.8M | 76.72%31.87M | 9.14%143.06M | -22.96%71.36M | -28.51%48.02M | -60.39%18.03M | -41.30%131.08M |
Cash outflows from operating activities | 10.11%322.29M | 11.25%1.32B | -8.56%770.06M | -11.80%523.23M | -14.61%292.7M | -6.64%1.19B | -20.91%842.13M | -25.62%593.24M | -6.68%342.79M | -39.84%1.28B |
Net cash flows from operating activities | 8.96%-123.52M | -939.66%-199.48M | -35.82%-169.6M | -13.09%-163.69M | -83.12%-135.67M | -72.39%23.76M | 48.19%-124.87M | 50.39%-144.74M | 50.86%-74.09M | 145.74%86.05M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | -93.39%41.42M | -46.51%1.62B | -47.51%1.32B | -24.38%1.22B | 63.82%626.46M | 114.21%3.03B | 130.50%2.51B | 99.91%1.62B | -6.05%382.41M | -62.79%1.41B |
Cash received from returns on investments | 53.42%22.31M | -27.66%31.59M | -28.55%30.21M | 19.06%29.41M | 15.86%14.54M | -3.10%43.67M | 9.28%42.28M | 14.16%24.7M | 18.98%12.55M | -18.56%45.06M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --148.2K | -0.34%1.25M | -98.83%5.05K | -99.05%4.1K | ---- | 7,928.69%1.25M | 3,175.46%430.1K | 3,175.46%430.1K | ---- | -94.07%15.58K |
Cash inflows from investing activities | -90.04%63.87M | -46.22%1.65B | -47.20%1.35B | -23.75%1.25B | 62.29%641M | 110.67%3.07B | 126.37%2.55B | 97.72%1.64B | -5.41%394.96M | -62.16%1.46B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -37.58%25.17M | -44.55%72.48M | 80.21%48.72M | 11,404.54%48.53M | 95,785.54%40.32M | 13,319.93%130.7M | 2,729.25%27.04M | -55.58%421.85K | -94.04%42.05K | -95.51%973.9K |
Cash paid to acquire investments | -99.18%3.25M | -56.81%1.28B | -53.90%1.07B | -39.48%901.99M | 23.52%396.28M | 85.05%2.96B | 113.53%2.31B | 83.43%1.49B | -35.77%320.83M | -54.68%1.6B |
Cash outflows from investing activities | -93.49%28.42M | -56.29%1.35B | -52.35%1.12B | -36.24%950.52M | 36.07%436.6M | 93.09%3.1B | 115.84%2.34B | 83.26%1.49B | -35.85%320.87M | -54.93%1.6B |
Net cash flows from investing activities | -82.65%35.45M | 1,472.48%300.08M | 9.95%231.69M | 97.46%303.29M | 175.88%204.4M | 84.83%-21.86M | 394.77%210.73M | 744.35%153.59M | 189.66%74.09M | -148.21%-144.15M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | --20.35M | --20.35M | ---- | ---- | ---- |
Cash from borrowing | 300.00%20M | 153.72%78.24M | --13.74M | --10M | --5M | --30.84M | ---- | ---- | ---- | ---- |
Cash inflows from financing activities | 300.00%20M | 52.85%78.24M | -32.49%13.74M | --10M | --5M | --51.19M | --20.35M | ---- | ---- | ---- |
Borrowing repayment | --9.5M | --44.57M | --44.57M | --34.99M | ---- | ---- | ---- | ---- | ---- | -82.94%6.86M |
Dividend interest payment | 27.99%408.82K | 508.00%540.89K | --608.89K | --451.3K | --319.42K | -62.29%88.96K | ---- | ---- | ---- | -87.35%235.92K |
Cash payments relating to other financing activities | -51.30%553.71K | 467.96%23.8M | 591.71%22.89M | 951.09%21.71M | 36.43%1.14M | 14.29%4.19M | 36.48%3.31M | 42.30%2.07M | 4.81%833.4K | 11.69%3.67M |
Cash outflows from financing activities | 618.37%10.46M | 1,510.23%68.92M | 1,956.80%68.08M | 2,667.10%57.15M | 74.76%1.46M | -60.23%4.28M | -65.23%3.31M | -63.63%2.07M | -8.33%833.4K | -76.27%10.76M |
Net cash flows from financing activities | 169.15%9.54M | -80.13%9.32M | -418.89%-54.34M | -2,182.91%-47.15M | 525.19%3.54M | 535.83%46.91M | 278.99%17.04M | 63.63%-2.07M | 8.33%-833.4K | 76.27%-10.76M |
Net cash flow | ||||||||||
Net increase in cash and cash equivalents | -208.66%-78.53M | 125.24%109.92M | -92.46%7.75M | 1,262.28%92.45M | 8,775.20%72.27M | 170.87%48.8M | 149.49%102.9M | 102.43%6.79M | 99.64%-833.08K | -205.13%-68.86M |
Add:Begin period cash and cash equivalents | 26.44%525.69M | 13.30%415.78M | 13.30%415.78M | 13.30%415.78M | 13.30%415.78M | -15.80%366.98M | -15.80%366.98M | -15.80%366.98M | -15.80%366.98M | 17.69%435.84M |
End period cash equivalent | -8.38%447.17M | 26.44%525.69M | -9.86%423.53M | 35.98%508.23M | 33.29%488.05M | 13.30%415.78M | 106.16%469.88M | 138.72%373.77M | 81.70%366.15M | -15.80%366.98M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.